Objective: To check whether subtle voiding dysfunction is related to recurrent urinary tract infection (rUTI). Methods: 254 consecutive patients with at least four episodes of urinary tract infection (UTI) were studied. At least three repeat urodynamic evaluations with an additional ice water test to maximize the detection of involuntary detrusor contraction (IDC) were used. Stress urinary incontinence cases were used as controls. Nonparametric univariate and multivariate analyses were used for statistics. Results: IDC was detected in 83.6% of patients in the rUTI group and in 31.7% in the control group. IDC was <15 cm H2O in 54.7% whereas high-amplitude (>50 cm H2O) IDC was observed in 6.8% in the rUTI group. Female urinary tract obstruction was diagnosed in 16.8% of patients in the rUTI group and in 7.9% in the control group. Residual volume, PdetQmax and Qmax were not predictive of UTI recurrence. Symptoms were similar in both groups. Conclusions: Patients with rUTI present with covert bladder dysfunctions represented by detrusor overactivity.

1.
Huang ES, Stafford RS: National patterns in the treatment of urinary tract infections in women by ambulatory care physicians. Arch Intern Med 2002;162:41-47.
2.
Bent S, Nallamothu BK, Simel DL, Fihn SD, Saint S: Does this woman have an acute uncomplicated urinary tract infection? JAMA 2002;287:2701-2710.
3.
Cardozo L, Stanton SL: Genuine stress incontinence and detrusor instability: a clinical and urodynamic review of 200 cases. Br J Obstet Gynaecol 1980;87:184-190.
4.
Jeffcoate TN, Francis WJ: Urgency incontinence in the female. Am J Obstet Gynecol 1966;94:604-618.
5.
Mishra B, Srivastava S, Singh K, Pandey A, Agarwal J: Symptom-based diagnosis of urinary tract infection in women: are we over-prescribing antibiotics? Int J Clin Pract 2012;66:493-498.
6.
Okorocha I, Cumming G, Gould I: Female urodynamics and lower urinary tract infection. BJU Int 2002;89:863-867.
7.
Moore KH, Simons A, Mukerjee C, Lynch W: The relative incidence of detrusor instability and bacterial cystitis detected on the urodynamic-test day. BJU Int 2000;85:786-792.
8.
Salinas Casado J, Tellez M, Virseda M, Carlos Ramírez J, Silmi Moyano A: Prevalencia de alteraciones urodinámicas en las infecciones urinarias recidivantes de la mujer. Arch Esp Urol 2007;60:1179-1188.
9.
Lapides J, Costello RT: Uninhibited neurogenic bladder: a common cause for recurrent urinary infection in normal women. J Urol 1969;101:539-544.
10.
Azadzoi KM, Tarcan T, Kozlowski R, Krane RJ, Siroky MB: Overactivity and structural changes in the chronically ischemic bladder. J Urol 1999;162:1768-1778.
11.
Azadzoi KM, Chen BG, Radisavljevic ZM, Siroky MB: Molecular reactions and ultrastructural damage in the chronically ischemic bladder. J Urol 2011;186:2115-2122.
12.
Rees DL, Whitfield HN, Islam AK, Doyle PT, Mayo ME, Wickham JE: Urodynamic findings in adult females with frequency and dysuria. Br J Urol 1975;47:853-860.
13.
Carlson KN, Rome S, Nitti VW: Dysfunctional voiding in women. J Urol 2001;165:143-147; discussion 147-148.
14.
Lecci A, Tramontana M, Giuliani S, Criscuoli M, Maggi CA: Effect of tachykinin NK2 receptor blockade on detrusor hyperreflexia induced by bacterial toxin in rats. J Urol 1998;160:206-209.
15.
Tanagho EA, Miller ER, Lyon RP, Fisher R: Spastic striated external sphincter and urinary tract infection in girls. Br J Urol 1971;43:69-82.
16.
Glassberg KI, Combs AJ, Horowitz M: Nonneurogenic voiding disorders in children and adolescents: clinical and videourodynamic findings in 4 specific conditions. J Urol 2010;184:2123-2127.
17.
De Paepe H, Hoebeke P, Renson C, Van Laecke E, Raes A, Van Hoecke E, Van Daele J, Vande Walle J: Pelvic-floor therapy in girls with recurrent urinary tract infections and dysfunctional voiding. Br J Urol 1998;81(suppl 3):109-113.
18.
Gamé X, Castel-Lacanal E, Bentaleb Y, Thiry-Escudié I, De Boissezon X, Malavaud B, Marque P, Rischmann P: Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections. Eur Urol 2008;53:613-618.
19.
Harari D, Malone-Lee J, Ridgway GL: An age-related investigation of urinary tract symptoms and infection following urodynamic studies. Age Ageing 1994;23:62-64.
20.
Shekarriz B, Upadhyay J, Freedman AL, Fleming P, Barthold JS, González R: Lack of morbidity from urodynamic studies in children with asymptomatic bacteriuria. Urology 1999;54:359-361; discussion 362.
21.
Callsen-Cencic P, Mense S: Expression of neuropeptides and nitric oxide synthase in neurones innervating the inflamed rat urinary bladder. J Auton Nerv Syst 1997;65:33-44.
22.
Rodrigues P, Hering F, Dias EC: Female obstruction after incontinence surgery may present different urodynamic patterns. Int Urogynecol J 2013;24:331-336.
23.
Choe JH, Lee JS, Seo JT: Urodynamic studies in women with stress urinary incontinence: significant bacteriuria and risk factors. Neurourol Urodyn 2007;26:847-851.
24.
Nilsson CG, Kuuva N, Falconer C, Rezapour M, Ulmsten U: Long-term results of the tension-free vaginal tape (TVT) procedure for surgical treatment of female stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2001;12(suppl 2):S5-S8.
25.
Broekhuis SR, Kluivers KB, Hendriks JC, Massolt ET, Groen J, Vierhout ME: Reproducibility of same session repeated cystometry and pressure-flow studies in women with symptoms of urinary incontinence. Neurourol Urodyn 2010;29:428-431.
26.
Gupta A, Defreitas G, Lemack GE: The reproducibility of urodynamic findings in healthy female volunteers: results of repeated studies in the same setting and after short-term follow-up. Neurourol Urodyn 2004;23:311-316.
27.
Akkad T, Pelzer AE, Mitterberger M, Rehder P, Leonhartsberger N, Bartsch G, Strasser H: Influence of intravesical potassium on pelvic floor activity in women with recurrent urinary tract infections: comparative urodynamics might lead to enhanced detection of dysfunctional voiding. BJU Int 2007;100:1071-1074.
28.
Flisser AJ, Walmsley K, Blaivas JG: Urodynamic classification of patients with symptoms of overactive bladder. J Urol 2003;169:529-533; discussion 533-534.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.